ArchPoint Investors’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$402K	Hold	115,055	–	–	0.1%	61
2025 Q4	$393K	Hold	115,055	–	–	0.09%	67
2025 Q3	$579K	Hold	115,055	–	–	0.16%	53
2025 Q2	$395K	Hold	115,055	–	–	0.12%	58
2025 Q1	$257K	Hold	115,055	–	–	0.08%	62
2024 Q4	$337K	Hold	115,055	–	–	0.11%	57
2024 Q3	$299K	Hold	115,055	–	–	0.1%	61
2024 Q2	$341K	Hold	115,055	–	–	0.13%	60
2024 Q1	$521K	Hold	115,055	–	–	0.22%	52
2023 Q4	$657K	Hold	115,055	–	–	0.27%	35
2023 Q3	$529K	Hold	115,055	–	–	0.2%	42
2023 Q2	$743K	Hold	115,055	–	–	0.29%	39
2023 Q1	$868K	Hold	115,055	–	–	0.38%	34
2022 Q4	$1.17M	Sell	115,055 -502,158	-81%	-$5.8M	0.55%	33
2022 Q3	$6.1M	Sell	617,213 -13,113	-2%	-$144K	2.49%	12
2022 Q2	$6.71M	Buy	630,326 +169,037	+37%	+$1.43M	2.66%	11
2022 Q1	$4.5M	Hold	461,289	–	–	1.55%	18
2021 Q4	$6.6M	Hold	461,289	–	–	1.96%	15
2021 Q3	$9.24M	Buy	+461,289	New	+$8.15M	2.77%	7